The nurse is reviewing a client's daily medications taken at home. Which of the following medications has a risk of dependency if used daily?
bisacodyl (Dulcolax)
psyllium (Metamucil)
polyethylene glycol (MiraLAX)
docusate sodium (Colace)
The Correct Answer is A
A. Bisacodyl is a stimulant laxative that can lead to dependency if used daily, as the body may become reliant on the medication for bowel movements. Chronic use can also result in electrolyte imbalances and diminished bowel function.
B. Psyllium is a bulk-forming laxative that works by increasing the bulk of stool and does not typically lead to dependency.
C. Polyethylene glycol is an osmotic laxative that can be used daily without a significant risk of dependency, as it draws water into the bowel to facilitate stool passage.
D. Docusate sodium is a stool softener that aids in preventing constipation but does not carry a risk of dependency when used regularly.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is C
Explanation
A. Allopurinol is a xanthine oxidase inhibitor used for chronic gout management and prevention, not for acute attacks.
B. Febuxostat is also used for chronic management of gout and not effective for immediate relief of an acute attack.
C. Colchicine is indicated for the treatment of acute gout flares as it helps reduce inflammation and pain associated with gout attacks.
D. Physostigmine is an antidote for anticholinergic toxicity and has no role in treating gout.
Correct Answer is B
Explanation
A. A high first-pass effect means that a significant amount of the drug is metabolized by the liver before reaching systemic circulation, making oral administration less effective.
B. Morphine with a high first-pass effect will be more effective when administered via non-enteral routes, such as IV or subcutaneous, to bypass the liver's initial metabolism.
C. The first-pass effect does not influence the kidney’s rate of excretion but rather the liver’s initial metabolism of the drug.
D. The liver, not the kidneys, is responsible for the first-pass metabolism, which occurs before the drug reaches systemic circulation when taken orally.